Consensus Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse 04:00:02 2024-05-10 pm EDT 5-day change 1st Jan Change
20.42 USD +0.94% Intraday chart for Organon & Co. +4.13% +41.61%

Evolution of the average Target Price on Organon & Co.

Price target over the last 5 years

History of analyst recommendation changes

c736557aa4.6eyO_rJi1xrj0d4UBmAr8Mt_GPLCFyEAXJ-UHQHasvA.n6rRpsQFvkm75Kg5MDhYnoQITbCqQ29ICvvHWTaog8CkuLupxw-4Vtu0uQ~e0650ef66a98cd776f390cc31bef0445
Piper Sandler Raiises Price Target on Organon to $24 From $22, Maintains Overweight Rating MT
Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating MT
Goldman Sachs Adjusts Price Target on Organon to $18 From $16, Keeps Neutral Rating MT
Piper Sandler Adjusts Organon & Co.'s Price Target to $22 From $32, Maintains Overweight Rating MT
Goldman Sachs Downgrades Organon to Neutral From Buy, Cuts Price Target to $16 From $33 MT
Morgan Stanley Adjusts Price Target on Organon to $22 From $27, Maintains Equal-Weight Rating MT
Barclays Initiates Organon With Overweight Rating, Price Target is $28 MT
Morgan Stanley Adjusts Price Target on Organon to $27 From $25, Maintains Equal-Weight Rating MT
Morgan Stanley Cuts Price Target on Organon to $25 From $26, Maintains Equal-Weight Rating MT
Raymond James Starts Organon & Co. at Outperform With $33 Price Target MT
Hot Wholesale Prices Print Saps Appetite for US Equities as Concern Mounts Rates Headed Higher MT
Marketmind: Growth trumps rates RE
Morgan Stanley Lowers Price Target for Organon to $24 From $27, Keeps Equalweight Rating MT
BofA Securities Downgrades Organon to Underperform From Neutral, Adjusts Price Target to $25 From $37 MT
Morgan Stanley Lowers Organon & Co's Price Target to $27 From $35, Maintains Equalweight Rating MT
Piper Sandler Upgrades Organon & Co. to Overweight From Neutral, Adjusts Price Target to $34 From $37 MT
Goldman Sachs Trims Organon & Co's Price Target to $38 From $41, Keeps Buy Rating MT
BofA Securities Downgrades Organon to Neutral From Buy, Adjusts Price Target to $37 From $40 MT
Goldman Sachs Adjusts Price Target for Organon & Co to $41 From $42, Maintains Buy Rating MT
Morgan Stanley Trims Organon & Co's Price Target to $34 From $35, Maintains Equalweight Rating MT
Goldman Sachs Starts Organon & Co. at Buy With $40 Price Target MT
Morgan Stanley Adjusts Organon & Co.'s Price Target to $35 from $37, Keeps Equalweight Rating MT
Morgan Stanley Adjusts Organon & Co Price Target to $37 From $35, Maintains Equalweight Rating MT
ORGANON : Piper Sandler Starts Organon at Neutral With $35 Price Target MT
ORGANON : BofA Securities Starts Organon & Co. at Buy with $43 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
20.51 USD
Average target price
22.5 USD
Spread / Average Target
+9.70%
High Price Target
30 USD
Spread / Highest target
+46.27%
Low Price Target
16 USD
Spread / Lowest Target
-21.99%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Organon & Co.

Piper Sandler
Morgan Stanley
Goldman Sachs
Barclays
Raymond James
BofA Securities
Citigroup
JPMorgan Chase
Evercore ISI
Chardan
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
  1. Stock Market
  2. Equities
  3. OGN Stock
  4. Consensus Organon & Co.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW